Ads
related to: colorectal cancer survival rate- Newly Diagnosed Data
Explore Data In Newly Diagnosed
Patients With WT RAS* mCRC.
- Biomarker Testing
See The Importance Of Biomarker
Identification For Your Patients.
- Clinical Data & Studies
View Study Design, Safety Profile,
And Primary & Secondary Endpoints.
- Hypothetical Profiles
Find Clinical Characteristics That
Affect Your Treatment Decision.
- Newly Diagnosed Data
Search results
What's Going On With Colorectal Cancer Diagnostic-Focused Guardant Health Stock On Tuesday?
Benzinga via Yahoo Finance· 6 days agoTuesday, the FDA's staff reviewers raised concerns regarding Guardant Health Inc's (NASDAQ:GH)...
Guardant colon cancer test struggles to detect non-cancerous tumors, FDA says
MedTech Dive via Yahoo Finance· 5 days agoEarlier treatment could potentially cure the patient or prolong survival, FDA scientists said in...
Cancer in Canada: Increasing Cases, Decreasing Diagnoses
Medscape· 6 days agoThe numbers of cancer cases and deaths are rising in Canada, even as overall rates of cancer...
Panel recommends blood test to detect colon cancer for FDA approval
UPI· 3 days agocancers, and over a third of those cases are expected to be fatal. May 23 (UPI) -- A panel of U.S....
Support Early Detection Technology to Save the Lives of Black Cancer Patients - Los Angeles Sentinel
Los Angeles Sentinel· 5 days agoThe stark reality that Black women are 41% more likely to die from breast cancer than White women is a grim reminder of the systemic inequities that pervade our health care ...
MD Anderson Research Highlights: ASCO 2024 Special | Newswise
Newswise· 4 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 4 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
Blood Test for Colon Cancer Screening May Miss Some Precancers, FDA Staff Says
MedPage Today· 5 days agoFDA reviewers questioned the potential benefits of Guardant Health's blood-based test for colorectal...
F.D.A. Panel Endorses Safety of Colon-Cancer Blood Test
New York Times· 4 days agoA committee of experts that advises the Food and Drug Administration voted by large majorities on Thursday that a new blood test to screen people for colon and rectal cancers
... in Combination with anti-PD-1 for First Line Recurrent and/or Metastatic Head and Neck Cancer to...
ThePress.net· 3 days agoThe updated interim evaluation (data cut-off: August 31, 2023) of 19 enrolled patients in ASP-1929-181 study suggests that the novel treatment approach of ASP-1929 photoimmunotherapy in combination ...